Chaska, MN, United States of America

Jeff J Ross

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Surmodics, Inc.. Active years: 2014.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeff J Ross - Innovator in Biocompatible Matrices

Introduction

Jeff J Ross is a notable inventor based in Chaska, MN (US). He has made significant contributions to the field of biocompatible materials, particularly through his innovative patent. His work focuses on creating matrices that can be utilized in various medical applications.

Latest Patents

One of Jeff J Ross's key patents is titled "Poly-α(1→4)glucopyranose-based matrices with hydrazide crosslinking." This invention provides biocompatible and biodegradable matrices formed from poly-α(1→4)glucopyranose and reactive hydrazide groups. These matrices have potential applications in drug delivery and cell therapy, showcasing their versatility in medical treatments.

Career Highlights

Jeff J Ross is associated with Surmodics, Inc., a company known for its advancements in medical device technologies. His role at Surmodics has allowed him to further develop his innovative ideas and contribute to the company's mission of improving patient outcomes through cutting-edge solutions.

Collaborations

Throughout his career, Jeff has collaborated with talented individuals such as Emily R Rolfes and Gary W Opperman. These collaborations have likely enriched his work and led to further advancements in the field of biocompatible materials.

Conclusion

Jeff J Ross is a distinguished inventor whose work in biocompatible matrices has the potential to impact medical applications significantly. His innovative patent and contributions to Surmodics, Inc. highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…